Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

• Venous thrombosis is common in patients with severe COVID-19 pneumonia. • Many of these thromboses may be immunothromboses due to local inflammation, rather than thromboembolic disease. • Anticoagulated patients with COVID-19 pneumonia have a risk of major bleeding.

More information Original publication

DOI

10.1016/j.thromres.2020.05.049

Type

Journal article

Publication Date

2020-09-01T00:00:00+00:00

Volume

193

Pages

1 - 4

Total pages

3

Keywords

COVID-19, Critical care, Pulmonary embolism, SARS-CoV-2, Venous thromboembolism, Adult, Aged, Aged, 80 and over, Anticoagulants, Betacoronavirus, COVID-19, Coronavirus Infections, Critical Care, Dalteparin, Extracorporeal Membrane Oxygenation, Female, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral, Retrospective Studies, SARS-CoV-2, Tertiary Health Care, Thromboembolism, Ultrasonography, Doppler, United Kingdom, Young Adult